About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Erythromycin oxime is a stabilized derivative that protects the macrolide core from acid degradation. After metabolic conversion, it acts as a 50S ribosomal inhibitor blocking peptidechain elongation.
Benefits and Advantages
Used in acidstability research, macrolide derivatization studies, ribosomalinteraction modelling, and semisynthetic macrolide development.
Side Effects and Risks
Risks include QT prolongation, nausea, elevated liver enzymes, and hypersensitivity. Handle with protective macrolidederivative precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C37H67NO12 |
|---|---|
| Molecular Weight | 717.93 g/mol |
| CAS Number | 16843-01-9 |
| Storage Condition | Store in a cool, dry place; protect from light |
| Solubility | Soluble in water |
| Purity | Purity information is available upon request (COA). |
| IUPAC/Chemical Name | Erythromycin oxime derivative |
| InChl Key | Unavailable |
| InChl Code | Unavailable |
| References | PubChem; ChemBL; FDA; |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
